SCHEMBL25842371

SCHEMBL25842371

Clc1cccc(N(c2cc(-c3ccccc3)cc(N(c3cccc(Cl)c3)c3ccccc3-c3ccccc3)c2)c2ccccc2-c2ccccc2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ CYP2A6 P11509 1/20 0.34
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ TP53 P04637 2/20 0.33
▸ LTB4R2 Q9NPC1 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ PTAFR P25105 1/20 0.33
▸ HTR3E A5X5Y0 1/20 0.33
▸ HTR3B O95264 1/20 0.33
▸ HTR3A P46098 1/20 0.33
▸ HTR3D Q70Z44 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20871969 0.91 MAPT (0.39) MEN1KMT2ARXFP1MAPTCYP2A6
SCHEMBL20871531 0.90 LTB4R2 (0.38) MAPTCYP2A6NPC1RAB9ATP53
SCHEMBL25765456 0.87 MEN1 (0.37) MEN1KMT2ARXFP1MAPTCYP2A6
SCHEMBL24491411 0.86 CYP2A6 (0.39) MEN1KMT2ARXFP1MAPTCYP2A6
SCHEMBL15038526 0.86 MGLL (0.35) MEN1KMT2AMAPTCYP2A6NPC1
SCHEMBL26002291 0.86 ALDH1A1 (0.35) MEN1KMT2ARXFP1MAPTCYP2A6
SCHEMBL25355364 0.86 MAPT (0.33) MEN1KMT2AMAPTCYP2A6NPC1
SCHEMBL26002263 0.85 TACR1 (0.35) MAPTTP53LTB4R2PTAFRHTR3E
SCHEMBL21250625 0.84 ACMSD (0.37) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL15038388 0.84 MGLL (0.38) MEN1KMT2AMAPTCYP2A6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230225207-A1 LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE SAME, AND THE CONDENSED CYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-13 — — US disclosed
US-20230225207-A1 LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE SAME, AND THE CONDENSED CYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230225207-A1 LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE SAME, AND THE CONDENSED CYCLIC COMPOUND CRY1, CRY2, CCNE2 MEN1 683/4885KMT2A 1410/4885RXFP1 4076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback